Results 271 to 280 of about 1,044,818 (308)
Some of the next articles are maybe not open access.
Immunology Today, 1988
Abstract Reproducible and efficient production of human monoclonal antibodies of predefined specificity has proved to be a notoriously difficult task. Many variations on basic production techniques now exist and, as Keith Thompson reviews here, the comparative ease with which they can now be made promises to open up numerous new research avenues.
openaire +2 more sources
Abstract Reproducible and efficient production of human monoclonal antibodies of predefined specificity has proved to be a notoriously difficult task. Many variations on basic production techniques now exist and, as Keith Thompson reviews here, the comparative ease with which they can now be made promises to open up numerous new research avenues.
openaire +2 more sources
Understanding monoclonal antibodies
Drug and Therapeutics Bulletin, 2007Elsewhere in this issue, we review new treatments for neovascular age-related macular degeneration,1 of which, â–¼bevacizumab and â–¼ranibizumab are monoclonal antibodies. These are two of a growing number of monoclonal antibodies currently available for therapeutic use in the UK.
openaire +2 more sources
Monoclonal antibodies in myeloma.
Clinical advances in hematology & oncology : H&O, 2015The development of monoclonal antibodies (mAbs) for the treatment of disease goes back to the vision of Paul Ehrlich in the late 19th century; however, the first successful treatment with a mAb was not until 1982, in a lymphoma patient. In multiple myeloma, mAbs are a very recent and exciting addition to the therapeutic armamentarium. The incorporation
Sondergeld, P. +3 more
openaire +5 more sources
Monoclonal Antibody TfR Monoclonal Antibody
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2017openaire +2 more sources